Plasma Proteome Profiling to Assess Human Health and Disease

Abstract

Proteins in the circulatory system mirror an individual's physiology. In daily clinical practice, protein levels are generally determined using single-protein immunoassays. High-throughput, quantitative analysis using mass-spectrometry-based proteomics of blood, plasma, and serum would be advantageous but is challenging because of the high dynamic range of protein abundances. Here, we introduce a rapid and robust "plasma proteome profiling" pipeline. This single-run shotgun proteomic workflow does not require protein depletion and enables quantitative analysis of hundreds of plasma proteomes from 1 μl single finger pricks with 20 min gradients. The apolipoprotein family, inflammatory markers such as C-reactive protein, gender-related proteins, and >40 FDA-approved biomarkers are reproducibly quantified (CV <20% with label-free quantification). Furthermore, we functionally interpret a 1,000-protein, quantitative plasma proteome obtained by simple peptide pre-fractionation. Plasma proteome profiling delivers an informative portrait of a person's health state, and we envision its large-scale use in biomedicine.

Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status

“…4b), we first filtered out the roughly 200 most abundant plasma proteins69. A minimum number of 30 valid values out of 41 was required, resulting in 6,649 proteins.…”

Principal Component Analysis with Linear and Quadratic Discriminant Analysis for Identification of Cancer Samples Based on Mass Spectrometry

“…The control population was composed of men with no previous history of prostate cancer and serum PSA < 1 ng mL -1 . The prostate cancer samples were acquired from patients with serum PSA ≥ 4 ng mL -1 , digital rectal exam (DRE) evidence and single sextant biopsy evidence of prostate cancer (Gleason scores [4][5][6][7][8][9]. More details about the sample acquisition can be found in Petricoin III et al 16 …”

“…2,3 This technique has been increasingly utilized in biomedical and clinical research, 4 since it can overcome many limitations of classical immunoassays 5,6 and supports the development of fast and less-invasive clinical procedures. [7][8][9] MS is usually coupled with chromatography such as liquid chromatography (LC-MS) and gas chromatography (GC-MS). Other techniques such as surface-enhanced laser desorption ionization time-of-flight (SELDI-TOF) and matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) are often used in MS applications, including disease screening and diagnosis.…”

Big data and stratified medicine: what does it mean for children?

“…Plasma contains many high and medium abundance proteins, while biomarkers are more likely to be lower abundance proteins. This requires extensive processing of the sample, for example, reducing high abundance proteins by immunodepletion and fractionation of samples, which increases variability and decreases throughput 36. However, improved techniques now enable detection of greater number of proteins, while requiring a smaller starting plasma volume 36 37.…”